The burgeoning popularity of semaglutide, often recognized by brand names like copyright and Wegovy, has sparked significant interest regarding its impact for weight management. Initially approved for treating type 2 diabetes, its noticeable capacity to encourage fullness and decrease appetite has led to its increasing use—both recommended and so